ADHD / ADD
attention deficit disorder
What is ADD / ADHD?
ADHD has many facets – Neurofeedback may help – ADHD Munich
Attention deficit disorder - ADHD & ADD
ADHD belongs to the most frequently assigned diagnoses in the child and youth age. His main symptoms include attention deficit, impulsivity and hyperactivity. According to the latest studies, approximately 6.1% of 0-17 year-olds (at a maximum of 13.9% in 9-year-old boys) and 0.4% of adults are diagnosed with ADHD – with an upward trend. Boys are affected more often than girls. Affected people often complain about unstructuredness, difficulties in staying in business, (daily) organization, forgetfulness, easy distraction, physical restlessness and wriggling, feelings of being “on the go”, interrupting others, impatience or excessive talking. – ADHD Munich
(Bachmann CJ, Philipsen A, Hoffmann F: ADHD in Germany: trends in diagnosis and pharmacotherapy—a country-wide analysis of health insurance data on attention-deficit/hyperactivity disorder (ADHD) in children, adolescents and adults from 2009–2014. Dtsch Arztebl Int 2017; 114: 141–8. DOI: 10.3238/arztebl.2017.0141)
Impulsivity
Hyperactivity
Attention deficit
Concentration difficulties
Successful ADHD treatment in our practice in Munich
How neurofeedback in our practice in Munich can help with ADHD
Objective diagnostics for ADHD / ADD
Especially in the case of suspected ADD & ADHD, a quantitative EEG can make a significant contribution to diagnostics. Individual subforms that go beyond the simple classification of ADD or ADHD can be distinguished. Also simple attention and concentration difficulties can be represented in such a way. Subsequently, a completely individual neurofeedback protocol can be created, which precisely approaches the conspicuous activity patterns.
Neurofeedback Therapy for ADHD / ADD
Neurofeedback can be used as the sole treatment, but also in combination with other forms of therapy. Neurofeedback treatment can also be started under existing medication. The aim is to reduce the symptoms and reduce medication taken. Restlessness and impulsiveness can be reduced, the ability to concentrate and the organisation improved. Especially since neurofeedback can also be carried out with exciting content such as films, games or music, it is easy to get started and children are highly motivated.
ADHD is one of the best-known areas of application for neurofeedback, as people with ADHD often experience an improvement very quickly. This applies to children as well as adolescents and adults. – ADHD Munich
Success cases with ADHD / ADD in our practice in munich
Many ADHD / ADD patients report a strong reduction of the respective symptoms. Particularly in the areas of attention and concentration, great progress is being made. In addition, our patients often find that they can pursue their everyday life in a more balanced manner. This has a direct positive effect on the environment of the person concerned in relationships and school, studies or work.
In children with ADHD in particular, significant motoric improvements can be observed. This is most clearly visible in the typeface. The following pictures show the course of the typeface with Ritalin / without Ritalin and after 20 neurofeedback sessions. The differences and positive sustainable effects of neurofeedback are clearly visible in the right picture.
Current study on ADHD and neurofeedback
The effectiveness of neurofeedback in ADHD was proven in the following meta-analysis in 2018, among others
Neurofeedback proven to be a non-drug treatment option for ADHD
"Our meta-analytical results of the Neurofeedback treatment indicate a sustained reduction in symptoms over time. The improvements are comparable to active treatments (including medication). Neurofeedback is therefore a non-drug treatment option for ADHD with proven positive effects that continue even after treatment is over."
Titel: Sustained effects of neurofeedback in ADHD: a systematic review and meta‑analysis – 05. Februar 2018
Quelle: Van Doren, J., Arns, M., Heinrich, H. et al. Eur Child Adolesc Psychiatry (2018). https://doi.org/10.1007/s00787-018-1121-4
Please contact us
We are subject to medical confidentiality and treat your data strictly confidential
By sending your message by clicking on the “Send” button, you accept our privacy policy. We are subject to medical confidentiality and treat your data strictly confidential.
